AtriCure to Participate in the Stifel 2023 Healthcare Conference
31 Ottobre 2023 - 1:00PM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments for atrial fibrillation (Afib), left atrial appendage
(LAA) management, and post-operative pain management, today
announced that the company will be participating in the upcoming
Stifel 2023 Healthcare Conference.
AtriCure’s management is scheduled to participate in a fireside
chat on Tuesday, November 14, 2023, at 10:55 a.m. Eastern Standard
Time. Interested parties may access a live audio webcast by
visiting the “Investors” section of the company’s website at
https://ir.atricure.com.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 37
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first medical
device to receive FDA approval for the treatment of persistent
Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System
products are the most widely sold LAA management devices worldwide.
AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure
that provides a lasting solution for long-standing persistent Afib
patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for
temporary ablation of peripheral nerves to block pain, providing
pain relief in cardiac and thoracic procedures. For more
information, visit AtriCure.com or follow us on Twitter
@AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231031704723/en/
Angie Wirick AtriCure, Inc. Chief Financial Officer (513)
755-5334 awirick@atricure.com
Lynn Lewis or Marissa Bych Gilmartin Group Investor Relations
lynn@gilmartinir.com marissa@gilmartinir.com
Grafico Azioni AtriCure (NASDAQ:ATRC)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni AtriCure (NASDAQ:ATRC)
Storico
Da Mag 2023 a Mag 2024